For the current REF see the REF 2021 website REF 2021 logo

Output details

1 - Clinical Medicine

University of Leeds

Return to search Previous output Next output
Output 0 of 0 in the submission
Article title

Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial

Type
D - Journal article
Title of journal
The Lancet
Article number
-
Volume number
381
Issue number
9877
First page of article
1541
ISSN of journal
0140-6736
Year of publication
2013
URL
-
Number of additional authors
10
Additional information

"The author made a substantial contribution to the conception and design of the study"

"The author made a substantial contribution to the organisation and conduct of the study"

"The author made a substantial contribution to carrying out the study (including acquisition of study data)"

"The author made a substantial contribution to analysis and interpretation of study data"

"The author helped draft the output"

"The author helped critique the output for important intellectual content"

Interdisciplinary
-
Cross-referral requested
-
Research group
C - Musculoskeletal
Citation count
11
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-